Tempest Therapeutics Inc Quick Ratio (TPST) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Tempest Therapeutics Inc   (NASDAQ: TPST)

Tempest Therapeutics Inc 's Quick Ratio

TPST's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.18 a new company low.

Within Major Pharmaceutical Preparations industry 421 other companies have achieved higher Quick Ratio than Tempest Therapeutics Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1699 to 3473.

Explain Quick Ratio?
How much Cash & cash equivalents TPST´s has?
What are TPST´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TPST Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change -26.3 % -82.9 % -84.11 % -81.91 % -55.67 %
Y / Y Cash & cash equivalent Change -94.54 % -91.61 % -74.54 % -66.02 % -54.12 %
Quick Ratio MRQ 0.18 0.87 3.63 3.16 2.37
TPST's Total Ranking # 3473 # 1699 # 740 # 735 # 848
Seq. Current Liabilities Change 114.77 % -2.36 % -10.77 % -60.62 % -50.17 %
Seq. Cash & cash equivalent Change -56.84 % -76.58 % 2.57 % -47.38 % -33.62 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 422
Healthcare Sector # 830
Overall Market # 3473


Quick Ratio Statistics
High Average Low
50.74 10.07 0.18
(Jun 30 2018)   (Jun 30 2026)




Financial Statements
Tempest Therapeutics Inc 's Current Liabilities $ 4 Millions Visit TPST's Balance sheet
Tempest Therapeutics Inc 's Cash & cash equivalent $ 1 Millions Visit TPST's Balance sheet
Source of TPST's Sales Visit TPST's Sales by Geography


Cumulative Tempest Therapeutics Inc 's Quick Ratio

TPST's Quick Ratio for the trailling 12 Months

TPST Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -75.31 % -75.86 % -54.65 % -24.8 % 16.83 %
Y / Y Cash & cash equivalent TTM Growth -79.81 % -70.19 % -55.96 % -41.05 % -22.52 %
Quick Ratio TTM 1.62 2.48 2.25 2.17 1.97
Total Ranking TTM # 3919 # 2891 # 2901 # 2932 # 2949
Seq. Current Liabilities TTM Growth -12.59 % -44.34 % -33.14 % -24.11 % -14.52 %
Seq. Cash & cash equivalent TTM Growth -43.13 % -38.63 % -30.66 % -16.56 % -16.04 %

Quick ratio ranking by company, industry and sector >> Back to TPST Financial Strength Comparisons >> Go to Compare TPST Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in TPST's Current Liabilities to $4.45 millions, cumulative Quick Ratio to 1.62 below the TPST average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 434 other companies have achieved higher Quick Ratio than Tempest Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2891 to 3919.

Explain Quick Ratio?
How much Cash & cash equivalents TPST´s has?
What are TPST´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 435
Healthcare Sector # 890
Within the Market # 3919


trailing twelve months Quick Ratio Statistics
High Average Low
15.34 4.53 1.22
(Jun 30 2013)   (Jun 30 2026)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Aytu Biopharma Inc  0.48 $ 26.308  Millions$ 54.659  Millions
Jupiter Neurosciences Inc   0.47 $ 1.522  Millions$ 3.251  Millions
Aeon Biopharma inc   0.47 $ 3.431  Millions$ 7.342  Millions
Evolus Inc   0.46 $ 45.170  Millions$ 98.731  Millions
Biomarin Pharmaceutical Inc  0.45 $ 874.005  Millions$ 1,927.164  Millions
Pds Biotechnology Corp  0.45 $ 5.596  Millions$ 12.377  Millions
Biofrontera Inc   0.44 $ 4.659  Millions$ 10.541  Millions
Beyondspring Inc   0.43 $ 10.361  Millions$ 23.834  Millions
Organon and Co   0.43 $ 1,132.000  Millions$ 2,616.000  Millions
Gossamer Bio Inc   0.41 $ 57.026  Millions$ 137.783  Millions
Bausch Health Companies Inc   0.39 $ 1,825.000  Millions$ 4,687.000  Millions
Johnson and Johnson  0.38 $ 21,094.000  Millions$ 54,895.000  Millions
Ultragenyx Pharmaceutical Inc   0.36 $ 125.000  Millions$ 351.000  Millions
Vanda Pharmaceuticals Inc   0.34 $ 56.119  Millions$ 164.026  Millions
Ainos Inc   0.29 $ 1.423  Millions$ 4.928  Millions
Elanco Animal Health Incorporated  0.29 $ 530.000  Millions$ 1,852.000  Millions
Provectus Biopharmaceuticals Inc   0.27 $ 1.157  Millions$ 4.234  Millions
Vireo Growth Inc.  0.27 $ 104.100  Millions$ 390.700  Millions
Phibro Animal Health Corporation  0.26 $ 81.994  Millions$ 316.468  Millions
Merck and Co Inc   0.26 $ 7,141.000  Millions$ 27,731.000  Millions
Indivior Pharmaceuticals Inc   0.26 $ 222.000  Millions$ 868.000  Millions
Propanc Biopharma Inc   0.25 $ 0.832  Millions$ 3.354  Millions
Teva Pharmaceutical Industries Limited  0.23 $ 3,655.000  Millions$ 15,646.000  Millions
Cytodyn inc   0.22 $ 11.852  Millions$ 53.727  Millions
Collegium Pharmaceutical Inc   0.22 $ 129.467  Millions$ 589.861  Millions
International Stem Cell Corporation  0.22 $ 1.089  Millions$ 4.984  Millions
Earth Science Tech Inc   0.22 $ 0.631  Millions$ 2.902  Millions
Viatris Inc   0.22 $ 1,368.700  Millions$ 6,345.800  Millions
Eli Lilly And Company  0.19 $ 8,950.000  Millions$ 47,741.000  Millions
Polomar Health Services, Inc.  0.18 $ 0.188  Millions$ 1.063  Millions

Date modified: 2026-09-03T12:19:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.